Cash Flow Delta-Fly Pharma, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,623.00
-1,718.00
-1,426.00
-1,325.00
-964.00
-859.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
49.00
-124.00
129.00
16.00
17.00
131.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-1,557.00
-1,834.00
-1,279.00
-1,303.00
-940.00
-726.00
Cash Flow from Investing Activities
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
1,363.00
756.00
1,853.00
882.00
119.00
875.00
Net Cash Inflow / Outflow
-193.00
-1,078.00
572.00
-424.00
-820.00
144.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
-1.00
-3.00
0.00
-3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Delta-Fly Pharma, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-1623.446
698
-2,321.00
-332.59%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
49.094
1304
-1,255.00
-96.24%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-1557.073
3278
-4,835.00
-147.50%
Cash Flow from Investing Activities
0
-1975
1,975.00
100.00%
Cash Flow from Financing Activities
1363.687
-181
1,544.00
853.42%
Net Cash Inflow / Outflow
-193.376
1122
-1,315.00
-117.23%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.01
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 15.13% vs -43.37% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-1,557.07
-1,834.58
15.13%
Footer loading
